Smart Membranes for Biomolecular Detection

Award Information
Agency: Department of Health and Human Services
Branch: N/A
Contract: 1R41EB004749-01
Agency Tracking Number: EB004749
Amount: $100,000.00
Phase: Phase I
Program: STTR
Awards Year: 2004
Solitcitation Year: N/A
Solitcitation Topic Code: N/A
Solitcitation Number: N/A
Small Business Information
20/20 GENESYSTEMS, INC.
20/20 GENESYSTEMS, INC., 9900 GREAT SENECA HWY, ROCKVILLE, MD, 20850
Duns: N/A
Hubzone Owned: N
Woman Owned: N
Socially and Economically Disadvantaged: N
Principal Investigator
 TIMOTHY BARBARI
 (301) 405-2983
 BARBARI@UMD.EDU
Business Contact
Phone: (240) 453-6339
Research Institution
 UNIVERSITY OF MARYLAND COLLEGE PK CAMPUS
 UNIVERSITY OF MARYLAND COLL PARK
COLLEGE PARK, MD, 20742
 Nonprofit college or university
Abstract
DESCRIPTION (provided by applicant): The main objective of this project is to develop membranes with surfaces tailored for specific affinity for a particular protein or nucleic acid molecule. These 'smart' membranes will be used in the next generation of high throughput Layered Expression Scanning (LES) applications, such as tissue screening and analytical blotting (northern and western). The heart of this technology is a stack of novel membranes that allows a sample to be transferred directly through the stack creating nearly identical replicas. The membranes must be moderately porous and permeable, must allow for less than 5% lateral diffusion, must have high specificity of binding, must have high affinity for binding, and should be easily fabricated. During Phase I of this proposal, we will (1) construct 'smart' membrane prototypes (specific for 5 nucleic acid sequences) and will demonstrate their ability to specifically, and in a concentration-dependent manner, capture individual nucleic acid (NA) sequences from (i) liquid samples and (ii) gel samples following separation by electrophoresis, and (2) optimize a 'smart' membrane stack for capturing targeted nucleic acids. In Phase II, we plan to extend the basic platform concept to selective protein binding using antibodies tethered to the membrane surface through specific biological interactions and develop a diagnostic platform that can be used for molecular profiling of actual clinical samples.

* information listed above is at the time of submission.

Agency Micro-sites

US Flag An Official Website of the United States Government